Home › Research › Caregiving
Decreased brain dopaminergic transporters in HIV-associated dementia patients
Wang GJ, Chang L, Volkow ND, Telang F, Logan J, Ernst T, Fowler JS.. Brain : a journal of neurology, 2004-08-19
Topic: Risk, prevention and care in population studies
Plain-language summary
HIV has a propensity to invade subcortical regions of the brain, which may lead to a subcortical dementia termed HIV-cognitive motor complex. Therefore, we aimed to assess whether dopamine (DA) D2 receptors and transporters (DAT) are affected in the basal ganglia of subjects with HIV, and how these changes relate to dementia status. Fifteen HIV subjects (age 44.5 +/- 11 years; CD4 185 +/- 130/mm3)) and 13 seronegative controls (42 +/- 12 years) were evaluated with PET to assess availability of DAT ([11C]cocaine) and DA D2 receptor ([11C]raclopride). HIV patients with associated dementia (HAD), but not those without dementia (ND) had significantly lower DAT availability in putamen (-19.3%, P = 0.009) and ventral striatum (-13.6%, P = 0.03) compared with seronegative controls. Higher plasma viral load in the HIV dementia patients correlated with lower DAT in the caudate (r = -0.7, P = 0.02) and putamen (r = -0.69, P = 0.03). DA D2 receptor availability, however, showed mild and non-significant decreases in HIV patients. These results provide the first evidence of DA terminal injury in HIV dementia patients, and suggest that decreased DAT may contribute to the pathogenesis of HIV dementia. The greater DAT decrease in the putamen than in the caudate parallels that observed in Parkinson's disease. The inverse relationship between viral burden and DAT availability further supports HIV-mediated neurotoxicity to dopaminergic terminals.
What this study adds
Evidence grade: Low
In 15 HIV subjects and 13 controls, HIV patients with dementia, but not those without, had significantly lower dopamine transporter availability in the putamen and ventral striatum, while dopamine D2 receptor availability showed only mild, non-significant decreases. Reported effect size: 19.3%; 13.6%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Wang, G. J., Chang, L., Volkow, N. D., Telang, F., Logan, J., Ernst, T., et al. (2004). Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain : a journal of neurology. https://doi.org/10.1093/brain/awh269
Vancouver
Wang GJ, Chang L, Volkow ND, Telang F, Logan J, Ernst T, et al. Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain : a journal of neurology. 2004. doi:10.1093/brain/awh269. PMID: 15319273.
BibTeX
@article{wang2004-15319273,
author = {Wang, G. J. and Chang, L. and Volkow, N. D. and Telang, F. and Logan, J. and Ernst, T. and Fowler, J. S.},
title = {{Decreased brain dopaminergic transporters in HIV-associated dementia patients}},
journal = {Brain : a journal of neurology},
year = {2004},
doi = {10.1093/brain/awh269},
pmid = {15319273},
url = {https://doi.org/10.1093/brain/awh269}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- HIV patients with associated dementia (HAD), but not those without dementia (ND) had significantly lower DAT availability in putamen (-19.3%, P = 0.009) and ventral striatum (-13.6%, P = 0.03) compared with seronegative controls.
- DA D2 receptor availability, however, showed mild and non-significant decreases in HIV patients.
- These results provide the first evidence of DA terminal injury in HIV dementia patients, and suggest that decreased DAT may contribute to the pathogenesis of HIV dementia.
Why it matters
In 15 HIV subjects and 13 controls, HIV patients with dementia, but not those without, had significantly lower dopamine transporter availability in the putamen and ventral striatum, while dopamine D2 receptor availability showed only mild, non-significant decreases. The authors call this the first evidence of dopamine terminal injury in HIV dementia and suggest decreased transporter availability may contribute to its pathogenesis.
New to this subject? Start with our plain-English guide: Caregiving →
Study details
- Effect size19.3%; 13.6%
- Evidence strengthLow
How this study scored 44/100
Published in a leading specialty journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Brain : a journal of neurology) |
| Journal's citation record | 4 / 4 | Brain: journal h-index 503 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2004 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 217 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 9.0 citations a year over 24 year(s) since 2004 |
| Impact for its field and year | 3 / 6 | Cited 3.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 18 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author G.-J. Wang: h-index 12 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Brookhaven National Laboratory: institution h-index 992 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 15319273) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 44 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Caregiving from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.